These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 17626250)
1. Inhibition of SULT2B1b expression alters effects of 3beta-hydroxysteroids on cell proliferation and steroid hormone receptor expression in human LNCaP prostate cancer cells. He D; Falany CN Prostate; 2007 Sep; 67(12):1318-29. PubMed ID: 17626250 [TBL] [Abstract][Full Text] [Related]
2. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Arnold JT; Le H; McFann KK; Blackman MR Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203 [TBL] [Abstract][Full Text] [Related]
3. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. Yang Q; Titus MA; Fung KM; Lin HK J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593 [TBL] [Abstract][Full Text] [Related]
4. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study. Chen J; Wang WQ; Lin SX J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106 [TBL] [Abstract][Full Text] [Related]
5. SOX9 is expressed in normal prostate basal cells and regulates androgen receptor expression in prostate cancer cells. Wang H; McKnight NC; Zhang T; Lu ML; Balk SP; Yuan X Cancer Res; 2007 Jan; 67(2):528-36. PubMed ID: 17234760 [TBL] [Abstract][Full Text] [Related]
7. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches. Hoffmann J; Sommer A J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262 [TBL] [Abstract][Full Text] [Related]
8. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone. Mizokami A; Koh E; Izumi K; Narimoto K; Takeda M; Honma S; Dai J; Keller ET; Namiki M Endocr Relat Cancer; 2009 Dec; 16(4):1139-55. PubMed ID: 19608712 [TBL] [Abstract][Full Text] [Related]
9. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Zha S; Ferdinandusse S; Denis S; Wanders RJ; Ewing CM; Luo J; De Marzo AM; Isaacs WB Cancer Res; 2003 Nov; 63(21):7365-76. PubMed ID: 14612535 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells. Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays. Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747 [TBL] [Abstract][Full Text] [Related]
12. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation. Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317 [TBL] [Abstract][Full Text] [Related]
13. Rap2 regulates androgen sensitivity in human prostate cancer cells. Bigler D; Gioeli D; Conaway MR; Weber MJ; Theodorescu D Prostate; 2007 Oct; 67(14):1590-9. PubMed ID: 17918750 [TBL] [Abstract][Full Text] [Related]
14. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430 [TBL] [Abstract][Full Text] [Related]
15. Immunolocalization of androgen receptors, estrogen alpha receptors, and estrogen beta receptors in experimentally induced canine prostatic hyperplasia. Gallardo F; Lloreta J; García F; Moll X; Baró T; González LA; Morote J; Reventos J; Mogas T J Androl; 2009; 30(3):240-7. PubMed ID: 19136389 [TBL] [Abstract][Full Text] [Related]
16. JunD mediates androgen-induced oxidative stress in androgen dependent LNCaP human prostate cancer cells. Mehraein-Ghomi F; Lee E; Church DR; Thompson TA; Basu HS; Wilding G Prostate; 2008 Jun; 68(9):924-34. PubMed ID: 18386285 [TBL] [Abstract][Full Text] [Related]
17. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells. Kim J; Park H; Im JY; Choi WS; Kim HS Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072 [TBL] [Abstract][Full Text] [Related]
18. CYP7B1-mediated metabolism of dehydroepiandrosterone and 5alpha-androstane-3beta,17beta-diol--potential role(s) for estrogen signaling. Pettersson H; Holmberg L; Axelson M; Norlin M FEBS J; 2008 Apr; 275(8):1778-89. PubMed ID: 18331353 [TBL] [Abstract][Full Text] [Related]
19. Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation. Nunlist EH; Dozmorov I; Tang Y; Cowan R; Centola M; Lin HK J Steroid Biochem Mol Biol; 2004 Jul; 91(3):157-70. PubMed ID: 15276623 [TBL] [Abstract][Full Text] [Related]
20. 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats. Oliveira AG; Coelho PH; Guedes FD; Mahecha GA; Hess RA; Oliveira CA Steroids; 2007 Dec; 72(14):914-22. PubMed ID: 17854852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]